Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
Background: Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial effect of tolvaptan. The purpose of this study was...
Main Authors: | Kensuke Fujioka, Sumio Mizuno, Taro Ichise, Takao Matsui, Hiroaki Hirase, Masato Yamaguchi, Takahiko Aoyama, Masakazu Yamagishi, Noboru Fujino, Masa-aki Kawashiri, Kenshi Hayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Therapeutic Advances in Cardiovascular Disease |
Online Access: | https://doi.org/10.1177/1753944718819064 |
Similar Items
-
High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01) -
Associations between questionnaires on lifestyle and atherosclerotic cardiovascular disease in a Japanese general population: A cross-sectional study.
by: Hayato Tada, et al.
Published: (2018-01-01) -
Tolvaptan
by: Bharath Rangarajan, et al.
Published: (2014-01-01) -
Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
by: Masakazu Kobayashi, et al.
Published: (2023-05-01) -
Transient swallowing‐induced atrial tachycardia in a patient with genotyped hypertrophic cardiomyopathy
by: Noboru Fujino, et al.
Published: (2020-09-01)